Journal Guide

Blood Cells, Molecules & Diseases emphasizes not only blood cells, but also covers the molecular basis of hematologic disease and studies of the diseases themselves. This is an invaluable resource to all those interested in the study of hematology, cell biology, immunology, and human genetics.Research Areas include:• Hematolymphopoiesis• Genetics of Blood Cells and Proteins• Molecular Biology of Blood Cells and Proteins• Pathophysiology of Blood Cells and Proteins• Hematological Malignancies• Disorders of Blood Cells and Coagulation ProteinsNote to Authors - please use the "Submit your paper" button on the right when submittingBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

This journal is an international fully refereed journal that features review and original research articles on all clinical, laboratory, and experimental aspects of haemostasis and thrombosis. The journal is devoted to publishing significant developments worldwide in the field of blood coagulation, fibrinolysis, thrombosis, platelets and the kininogen-kinin system, as well as dealing with those aspects of blood rheology relevant to haemostasis and the effects of drugs on the haemostatic components.Blood Coagulation and Fibrinolysis publishes mutation reports detailing the mutated gene and giving a brief clinical history of the propositus. The journal also publishes correspondence and technical reports. The emphasis is on speed of publication. American Heart Association members are eligible for a discount on subscription rates.Website: www.bloodcoagulation.com.

Practical information on hemodialysis, hemofiltration, peritoneal dialysis, and apheresis is featured in this journal. Recognizing the critical importance of equipment and procedures, particular emphasis has been placed on reports, drawn from a wide range of fields, describing technical advances and improvements in methodology. Papers reflect the search for cost-effective solutions which increase not only patient survival, but also patient comfort and disease improvement by prevention or correction of undesirable effects. Advances in vascular access and blood anticoagulation, problems associated with exposure of blood to foreign surfaces, and acute-care nephrology, including continuous therapies, also receive attention. Nephrologists, internists, intensivists, and hospital staff involved in dialysis, apheresis, and immunoadsorption for acute and chronic solid organ failure will find this journal useful and informative. Blood Purification also serves as a platform for multidisciplinary experiences involving nephrologists, cardiologists, and critical care physicians in order to expand the level of interaction between different disciplines and specialties.

This respected international journal, Blood Reviews, is a vital information resource, bringing together appraisals of clinical practice, and research from recognized experts. Specially commissioned articles from leading researchers and practitioners guarantee truly global coverage of all the sub-specialties of hematology.Blood Reviews publishes review articles covering the spectrum of clinical and laboratory haematological practice and research. Although most reviews are invited, the editors welcome suggestions from potential authors. They should first write a brief outline of an intended review and send this to Dr Trevor Baglin (trevor.baglin@addenbrookes.nhs.uk) or to Dr Hillard Lazarus (hml@case.edu).Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Bone Marrow Transplantation publishes high quality, peer reviewed original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation.The broad scope of the journal thus encompasses topics such as stem cell biology, e.g., kinetics and cytokine control, transplantation immunology e.g., HLA and matching techniques, translational research, and clinical results of specific transplant protocols. Bone Marrow Transplantation publishes 12 issues a year.

The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology, Letters to the Editor and book reviews.

From Biology to Clinical practice : a modern approach of oncologyWhile giving space to review articles and paying more attention to biological aspects, the Bulletin du Cancer maintains a highly scientific clinical and therapeutic approach.The Bulletin du Cancer is one of the best scientific publications in the French language in the realm of cancerology. It is listed in the leading international databases.The Bulletin du Cancer is the official organ of the French Cancer Society.The online version of Bulletin du Cancer is available. All articles published since 1997 can now be accessed online. Recent articles are available by pay per view or by subscription while older ones have free access.

CA: A Cancer Journal for Clinicians is a peer-reviewed journal of the American Cancer Society providing cancer care professionals with up-to-date information on all aspects of cancer diagnosis, treatment, and prevention. Published six times per year, CA is the most widely circulated oncology journal in the world, with a circulation of approximately 76,000, including primary care physicians; medical, surgical, and radiation oncologists; nurses; other health care and public health professionals; and students in various health care fields. Although CA is an oncology journal, it is not a journal only for oncologists. It reaches a very wide and diverse group of professionals, and provides an unparalleled opportunity to present information to these professionals about cancer prevention, early detection, treatment of all forms, palliation, advocacy issues, quality-of-life topics, and more.

Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents. Each issue contains a series of timely in-depth reviews, original research articles and drug clinical trial studies written by leaders in the field covering a range of current topics in Cardiovascular & Hematological medicinal chemistry.

Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth, reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Written and edited by renowned professionals, each biweekly issue of Circulation Research explores some of the most revolutionary research from areas like cellular therapy, arrhythmias, nuclear mechanotransduction, gene therapy, stem cells and more.Online subscriptions are available to members of the American Heart Association/American Stroke Association as a benefit of membership depending on membership level. Members may also qualify for special rates on print subscriptions. Visit My.AmericanHeart.org for more information on membership benefits and to join/renew today!Ranked 2nd in Peripheral Vascular Disease and 3rd in Cardiac & Cardiovascular Systems and Hematology Subject Matter Categories (2008 Journal Citation Reports174;, Thomson Reuters, 2009).

Clinical Hemorheology and Microcirculation, a peer-reviewed international scientific journal, serves as an aid to understanding the flow properties of blood and the relationship to normal and abnormal physiology. The rapidly expanding science of hemorheology concerns blood, its components and the blood vessels with which blood interacts. It includes perihemorheology, i.e., the rheology of fluid and structures in the perivascular and interstitial spaces as well as the lymphatic system. The clinical aspects include pathogenesis, symptomatology and diagnostic methods, and the fields of prophylaxis and therapy in all branches of medicine and surgery, pharmacology and drug research.The endeavour of the Editors-in-Chief and publishers of Clinical Hemorheology and Microcirculation is to bring together contributions from those working in various fields related to blood flow all over the world. The editors of Clinical Hemorheology and Microcirculation are from those countries in Europe, Asia, Australia and America where appreciable work in clinical hemorheology and microcirculation is being carried out. Each editor takes responsibility to decide on the acceptance of a manuscript. He is required to have the manuscript appraised by two referees and may be one of them himself. The executive editorial office, to which the manuscripts have been submitted, is responsible for rapid handling of the reviewing process.Clinical Hemorheology and Microcirculation accepts original papers, brief communications, mini-reports and letters to the Editors-in-Chief. Review articles, providing general views and new insights into related subjects, are regularly invited by the Editors-in-Chief. Proceedings of international and national conferences on clinical hemorheology (in original form or as abstracts) complete the range of editorial features.The following professionals and institutions will benefit most from subscribing to Clinical Hemorheology and Microcirculation: medical practitioners in all fields including hematology, cardiology, geriatrics, angiology, surgery, obstetrics and gynecology, ophthalmology, otology, and neurology. Pharmacologists, clinical laboratories, blood transfusion centres, manufacturing firms producing diagnostic instruments, and the pharmaceutical industry will also benefit.Important new topics will increasingly claim more pages of Clinical Hemorheology and Microcirculation: the role of hemorheological and microcirculatory disturbances for epidemiology and prognosis, in particular regarding cardiovascular disorders, as well as its significance in the field of geriatrics. Authors and readers are invited to contact the editors for specific information or to make suggestions.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/725537/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Clinical and Applied Thrombosis/Hemostasis is dedicated to serving as a forum for studies regarding the etiology, pathophysiology, clinical diagnosis, laboratory diagnosis, and treatment of thrombohemorrhagic disorders. Articles dealing with new diagnostic procedures are encouraged, provided they are clinically oriented or potentially applicable to clinical and laboratory medicine. Articles dealing with all aspects of thrombosis, hemostasis, and vascular disorders of clinical or clinical laboratory applicability are also encouraged. The contents of the journal are of appeal to any person interested in clinical and applied thrombohemorrhagic disorders.